CWA
Clarus Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $513K | Buy |
998
+129
| +15% | +$66.3K | 0.31% | 69 |
|
|
2023
Q1 | $500K | Buy |
869
+1
| +0.1% | +$576 | 0.31% | 67 |
|
|
2022
Q4 | $493K | Sell |
868
-45
| -5% | -$25.6K | 0.32% | 63 |
|
|
2022
Q3 | $467K | Buy |
913
+69
| +8% | +$35.3K | 0.33% | 56 |
|
|
2022
Q2 | $471K | Buy |
844
+30
| +4% | +$16.7K | 0.33% | 55 |
|
|
2022
Q1 | $477K | Buy |
814
+41
| +5% | +$24K | 0.3% | 58 |
|
|
2021
Q4 | $483K | Sell |
773
-66
| -8% | -$41.2K | 0.28% | 56 |
|
|
2021
Q3 | $480K | Sell |
839
-57
| -6% | -$32.6K | 0.3% | 51 |
|
|
2021
Q2 | $461K | Sell |
896
-1,971
| -69% | -$1.01M | 0.29% | 60 |
|
|
2021
Q1 | $1.37M | Buy |
2,867
+37
| +1% | +$17.7K | 0.86% | 27 |
|
|
2020
Q4 | $1.45M | Sell |
2,830
-11
| -0.4% | -$5.65K | 0.97% | 27 |
|
|
2020
Q3 | $1.27M | Buy |
2,841
+54
| +2% | +$24.1K | 0.98% | 26 |
|
|
2020
Q2 | $1.06M | Buy |
2,787
+115
| +4% | +$43.7K | 0.89% | 26 |
|
|
2020
Q1 | $754K | Buy |
2,672
+13
| +0.5% | +$3.67K | 0.75% | 31 |
|
|
2019
Q4 | $876K | Sell |
2,659
-174
| -6% | -$57.3K | 0.58% | 40 |
|
|
2019
Q3 | $825K | Buy |
2,833
+2,039
| +257% | +$594K | 0.6% | 35 |
|
|
2019
Q2 | $233K | Sell |
794
-24
| -3% | -$7.04K | 0.17% | 100 |
|
|
2019
Q1 | $224K | Buy |
+818
| New | +$224K | 0.17% | 80 |
|